PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462787
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462787
Allergy Immunotherapy Market Forecasts to 2030 - Global Analysis By Type, Allergy Type, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Allergy Immunotherapy Market is accounted for $2.67 billion in 2023 and is expected to reach $5.77 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Allergy immunotherapy, also known as allergy shots or desensitization, is a treatment for allergies like pollen allergies, asthma, and food allergies. It works by gradually exposing the immune system to increasing amounts of allergens, retraining it to not overreact, and causing allergy symptoms. Unlike medications that just manage symptoms, immunotherapy offers the potential for a long-term solution or even a cure, making it a promising approach for those seeking relief from chronic allergies, thereby improving patient quality of life and reducing reliance on symptomatic medications.
According to the estimates of the American Academy of Allergy Asthma & Immunology, nearly 7.8% of the American population aged above 18 develops allergic rhinitis.
Market Dynamics:
Driver:
Rising prevalence of allergies
As more people develop allergies like asthma, hay fever, and food sensitivities, the demand for long-term solutions beyond just managing symptoms grows. Allergy immunotherapy offers a unique approach by gradually desensitizing the immune system to allergens, potentially curing allergies altogether. This increased need for a permanent solution, coupled with a growing population of allergy sufferers, creates a significant market opportunity for companies developing and delivering immunotherapy treatments.
Restraint:
Cost of treatment
Expenses associated with allergen extracts, physician visits, and monitoring for adverse reactions can be substantial. This financial burden may limit access to immunotherapy for some patients, particularly those without adequate financial resources. Also, the long-term nature of treatment and the need for continued follow-up appointments contribute to the overall cost, making it a barrier for individuals seeking this potentially beneficial therapy.
Opportunity:
Increasing focus on personalized medicine
The growing focus on personalized medicine unlocks a key opportunity for the Allergy Immunotherapy Market. By tailoring treatment plans to individual patients' specific allergies (considering factors like triggers, age, and medical history), personalized immunotherapy offers the potential for increased efficacy and improved safety. This targeted approach could make immunotherapy more attractive to a wider patient pool that might have been hesitant due to concerns about effectiveness or side effects, ultimately leading to significant market expansion.
Threat:
Alternative treatment options
Pharmacotherapy like antihistamines and corticosteroids, along with avoidance measures, compete with immunotherapy. These alternatives may be preferred by patients and healthcare providers due to convenience and perceived safety. This threatens market penetration and adoption rates of immunotherapy, potentially impacting revenue streams for providers and limiting the market's overall growth potential.
Covid-19 Impact
Initially, concerns about potential interactions and limited healthcare access caused disruptions, like delays in treatment initiation and a shift towards favoured sublingual immunotherapy methods (administered under the tongue) to minimize contact. However, the pandemic also highlighted the importance of managing chronic conditions like allergies, potentially leading to a future increase in demand for long-term solutions like immunotherapy.
The food allergy segment is expected to be the largest during the forecast period
The food allergy segment is estimated to hold the largest share. Immunotherapy for food allergies involves gradually exposing the body to increasing amounts of the allergenic food, with the goal of desensitizing the immune system and reducing the severity of allergic reactions. This targeted approach offers a potential cure for food allergies, as opposed to just managing symptoms, making it an attractive option for many patients. As food allergies become more prevalent, the segment is expected to see significant growth.
The retail pharmacy segment is expected to have the highest CAGR during the forecast period
The retail pharmacy segment is anticipated to have lucrative growth during the forecast period. Retail pharmacies stock a variety of allergen extracts, medications, and supplies necessary for immunotherapy treatments. Pharmacists at retail pharmacies provide counselling, education, and support to patients undergoing immunotherapy, ensuring proper administration, monitoring for adverse reactions, and optimizing treatment adherence. With their widespread presence and accessibility, retail pharmacies play a crucial role in expanding patient access to allergy immunotherapy and improving overall patient outcomes and satisfaction.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to growing prevalence of allergies, increasing disposable income, and a strong presence of major pharmaceutical companies in developing Asian markets. These companies are investing in advancements like sublingual immunotherapy and improved allergen standardization, making the treatment more accessible and efficient. This, coupled with rising awareness about allergy management, positions the Asia Pacific region as a major growth engine for the Allergy Immunotherapy Market.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period, owing to high prevalence of allergies, strong public awareness about immunotherapy as a treatment option, and a robust healthcare infrastructure that facilitates access. Moreover, North America serves as a hotbed for research and development in allergy immunotherapy, constantly innovating and introducing novel treatment methods.
Key players in the market
Some of the key players in the Allergy Immunotherapy Market include ALK Abello, Allergy Therapeutics, Stallergenes Greer, Mylan N.V., Arrayit Corporation, Merck KGaA, Biomay AG, HollisterStier Allergy, HAL Allergy Group, ASIT Biotech, LETIPharma, Dermapharm Holding SE, Carcassia, Anergis, DVB Technologies SA, Adamis Pharmaceuticals Corporation.
Key Developments:
In July 2022, Stallergenes Greer, a global healthcare company that specializes in allergen immunotherapy (AIT), announced the positive data related to the significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis
In April 2021, ALK initiated a clinical trial to study the safety and efficacy of sublingual immunotherapy tablets in children and adolescents suffering from allergic rhinitis induced by birch pollen.
Types Covered:
- Sublingual Immunotherapy
- Subcutaneous Immunotherapy
- Specific Immunotherapy
Allergy Types Covered:
- Allergic Asthma
- Allergic Rhinitis
- Atopic Dermatitis
- Food Allergy
- Other Allergy Types
Distribution Channels Covered:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
End Users Covered:
- Hospitals
- Clinics
- Diagnostic Centers
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Allergy Immunotherapy Market, By Type
- 5.1 Introduction
- 5.2 Sublingual Immunotherapy
- 5.3 Subcutaneous Immunotherapy
- 5.4 Specific Immunotherapy
6 Global Allergy Immunotherapy Market, By Allergy Type
- 6.1 Introduction
- 6.2 Allergic Asthma
- 6.3 Allergic Rhinitis
- 6.4 Atopic Dermatitis
- 6.5 Food Allergy
- 6.6 Other Allergy Types
7 Global Allergy Immunotherapy Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Hospital Pharmacy
- 7.3 Online Pharmacy
- 7.4 Retail Pharmacy
8 Global Allergy Immunotherapy Market, By End User
- 8.1 Introduction
- 8.2 Hospitals
- 8.3 Clinics
- 8.4 Diagnostic Centers
9 Global Allergy Immunotherapy Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 ALK Abello
- 11.2 Allergy Therapeutics
- 11.3 Stallergenes Greer
- 11.4 Mylan N.V.
- 11.5 Arrayit Corporation
- 11.6 Merck KGaA
- 11.7 Biomay AG
- 11.8 HollisterStier Allergy
- 11.9 HAL Allergy Group
- 11.10 ASIT Biotech
- 11.11 LETIPharma
- 11.12 Dermapharm Holding SE
- 11.13 Carcassia
- 11.14 Anergis
- 11.15 DVB Technologies SA
- 11.16 Adamis Pharmaceuticals Corporation
List of Tables
- Table 1 Global Allergy Immunotherapy Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 3 Global Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 4 Global Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 5 Global Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 6 Global Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 7 Global Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 8 Global Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 9 Global Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 10 Global Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 11 Global Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 12 Global Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 13 Global Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 14 Global Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 15 Global Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 16 Global Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 17 Global Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 18 Global Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 19 Global Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 20 North America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
- Table 21 North America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 22 North America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 23 North America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 24 North America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 25 North America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 26 North America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 27 North America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 28 North America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 29 North America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 30 North America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 31 North America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 32 North America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 33 North America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 34 North America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 35 North America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 36 North America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 37 North America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 38 North America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 39 Europe Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
- Table 40 Europe Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 41 Europe Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 42 Europe Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 43 Europe Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 44 Europe Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 45 Europe Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 46 Europe Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 47 Europe Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 48 Europe Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 49 Europe Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 50 Europe Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 51 Europe Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 52 Europe Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 53 Europe Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 54 Europe Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 55 Europe Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 56 Europe Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 57 Europe Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 58 Asia Pacific Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
- Table 59 Asia Pacific Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 60 Asia Pacific Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 61 Asia Pacific Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 62 Asia Pacific Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 63 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 64 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 65 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 66 Asia Pacific Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 67 Asia Pacific Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 68 Asia Pacific Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 69 Asia Pacific Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 70 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 71 Asia Pacific Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 72 Asia Pacific Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 73 Asia Pacific Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 74 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 75 Asia Pacific Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 76 Asia Pacific Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 77 South America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
- Table 78 South America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 79 South America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 80 South America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 81 South America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 82 South America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 83 South America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 84 South America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 85 South America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 86 South America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 87 South America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 88 South America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 89 South America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 90 South America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 91 South America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 92 South America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 93 South America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 94 South America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 95 South America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 96 Middle East & Africa Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
- Table 97 Middle East & Africa Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
- Table 98 Middle East & Africa Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
- Table 99 Middle East & Africa Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
- Table 100 Middle East & Africa Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
- Table 101 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
- Table 102 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
- Table 103 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
- Table 104 Middle East & Africa Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
- Table 105 Middle East & Africa Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
- Table 106 Middle East & Africa Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
- Table 107 Middle East & Africa Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 108 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 109 Middle East & Africa Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 110 Middle East & Africa Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 111 Middle East & Africa Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
- Table 112 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 113 Middle East & Africa Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
- Table 114 Middle East & Africa Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
